NURECA Share Price Target 2030

CAGR-based price projection for Nureca Limited (NURECA) targeting 2030, derived from official NSE exchange closing prices.

Bear Case (11.1% CAGR)
Rs 510
2030 Target
Base Case (27.9% CAGR)
Rs 893
2030 Target
Bull Case (82.5% CAGR)
Rs 3,710
2030 Target

Current Market Snapshot

CMP: Rs 334.25
52W High: Rs 343.95
52W Low: Rs 226.23
1Y CAGR: 63.5%
3Y CAGR: 27.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 371 Rs 427 Rs 610
2028 Rs 413 Rs 546 Rs 1,114
2029 Rs 459 Rs 699 Rs 2,033
2030 Rs 510 Rs 893 Rs 3,710

Other NURECA Price Targets

2025 2026 2027 2028 2035 2040 2050

Frequently Asked Questions

What is the NURECA share price target for 2030?

Based on historical growth analysis, the NURECA share price target for 2030 ranges from Rs 510 (conservative) to Rs 893 (base case) to Rs 3,710 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of NURECA?

The current market price of NURECA (Nureca Limited) is Rs 334.25. The 52-week high is Rs 343.95 and 52-week low is Rs 226.23.

Is NURECA a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for NURECA price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 11.1% CAGR), Base (27.9% CAGR), and Bull (optimistic at 82.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.